PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    NHS services in the UK cannot currently provide PrEP.But it is legal to buy PrEP drugs online and import them for your personal use.To use PrEP safely, you...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Mr Gay NZ defends his view that having unprotected sex with HIV can be safe

    The new Mr Gay New Zealand, who is HIV positive, is defending having unprotected sex, saying he always informs sexual partners of his health status. He said he only had unprotected sex with HIV positive men or HIV negative men who he knew were on Pre-exposure prophylaxis (PrEP), which was a pill that reduced the risk of them getting HIV.

    21 February 2017 | New Zealand Herald
  • PrEP uses contributes to decline in STI incidence among MSM

    Results from a modeling study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017 indicated that the use of pre-exposure prophylaxis for HIV prevention in addition to routine screening and treatment of sexually transmitted infections, or STIs, could reduce the incidence of STIs among men who have sex with men, even when condom use was reduced.

    20 February 2017 | Healio
  • Oral PrEP Works Well in Women With Abnormal Vaginal Microbiota

    This challenges a finding that an anti-HIV vaginal gel might not be effective in women with abnormal vaginal flora.

    16 February 2017 | Poz
  • Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

    The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

    16 February 2017 | Poz
  • One-stop sexual health: PrEP services at your local pharmacy

    Pharmacists—who work across centers that range from community clinics, to pharmacies in grocery stores, to stand-alone retail centers—may be an untapped resource as potential PrEP service providers. This was the subject up for discussion at a recent session at CROI, where two presenters shed light on the feasibility of pharmacist-delivered PrEP services.

    16 February 2017 | BETA blog
  • Born Free: dispelling misconceptions about conception and HIV

    Lolisa Gibson-Hunte never thought she wanted kids. But now Lolisa, who is HIV positive, and her husband, Daryl Hunte, who is HIV negative, have two children—and both kids are free of HIV.

    14 February 2017 | Poz
  • New ACON campaign shows there's now more to safe sex than just condoms

    Whilst condoms are mainstay of preventing HIV infections, ACON is sending a message that with options such as PrEP (pre-exposure prophylaxis) becoming more commonplace and UVL (undetectable viral load) a common catchphrase, there are other approaches to preventing transmission that don’t always involve a condom.

    13 February 2017 | Gay News Network
  • Gilead to use dating sites, Tumblr, and Snapchat in Truvada strategy

    Using platforms like Tumblr and Snapchat may help the company raise awareness about the preventative HIV drug Truvada among a population of people who don't engage with the healthcare system in traditional ways, Gilead said during a call with investors on Tuesday.

    13 February 2017 | Medical Marketing & Media
  • Case Report of PrEP Failure: What Can We Learn From It?

    The New England Journal of Medicine has published the first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure despite good medication adherence. We heard lots of this information at CROI last year, and again I'm impressed at the extraordinary degree of virologic investigation done on a case from clinical practice.

    08 February 2017 | The Body Pro
  • New HIV infections in gay men have dropped by a third in England

    New HIV infections in gay men have fallen by nearly a third since 2015 across England, New Scientist can reveal. And it may be down to people buying medicines online, against mainstream medical advice.

    03 February 2017 | New Scientist
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.